These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 22280423)

  • 1. Understanding the molecular and cellular changes behind aortic valve stenosis.
    Falcão-Pires I; Gavina C; Leite-Moreira AF
    Curr Pharm Biotechnol; 2012 Oct; 13(13):2485-96. PubMed ID: 22280423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aortic valve calcification: basic science to clinical practice.
    Akat K; Borggrefe M; Kaden JJ
    Heart; 2009 Apr; 95(8):616-23. PubMed ID: 18632833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and cellular mechanisms of aortic stenosis.
    Yetkin E; Waltenberger J
    Int J Cardiol; 2009 Jun; 135(1):4-13. PubMed ID: 19386374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathogenesis of calcific aortic valve stenosis].
    Kaden JJ
    Herz; 2006 Oct; 31(7):620-8. PubMed ID: 17072774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The progression of calcific aortic valve disease through injury, cell dysfunction, and disruptive biologic and physical force feedback loops.
    Li C; Xu S; Gotlieb AI
    Cardiovasc Pathol; 2013; 22(1):1-8. PubMed ID: 22795219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomics: the next step to elucidate the etiology of calcific aortic valve stenosis.
    Bossé Y; Mathieu P; Pibarot P
    J Am Coll Cardiol; 2008 Apr; 51(14):1327-36. PubMed ID: 18387432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular hypertrophy in isolated aortic stenosis: primetime for the ventricle.
    Gavina C; Falcão-Pires I; Rocha-Gonçalves F; Leite-Moreira A
    Curr Pharm Biotechnol; 2012 Oct; 13(13):2503-14. PubMed ID: 22280425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aortic stenosis: a general overview of clinical, pathophysiological and therapeutic aspects.
    Akerström F; Barderas MG; Rodríguez-Padial L
    Expert Rev Cardiovasc Ther; 2013 Feb; 11(2):239-50. PubMed ID: 23405844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of tissue factor in experimental aortic valve sclerosis.
    Marechaux S; Corseaux D; Vincentelli A; Richardson M; Ung A; Susen S; Zawadzki C; Beregi JP; Ezekowitz MD; Jude B; Le Tourneau T
    Cardiovasc Pathol; 2009; 18(2):67-76. PubMed ID: 18402835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcific Aortic Valve Disease: Part 2-Morphomechanical Abnormalities, Gene Reexpression, and Gender Effects on Ventricular Hypertrophy and Its Reversibility.
    Pasipoularides A
    J Cardiovasc Transl Res; 2016 Aug; 9(4):374-99. PubMed ID: 27184804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regression of myocardial hypertrophy after aortic valve replacement: faster in women?
    Petrov G; Regitz-Zagrosek V; Lehmkuhl E; Krabatsch T; Dunkel A; Dandel M; Dworatzek E; Mahmoodzadeh S; Schubert C; Becher E; Hampl H; Hetzer R
    Circulation; 2010 Sep; 122(11 Suppl):S23-8. PubMed ID: 20837918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms underlying the onset of degenerative aortic valve disease.
    Hakuno D; Kimura N; Yoshioka M; Fukuda K
    J Mol Med (Berl); 2009 Jan; 87(1):17-24. PubMed ID: 18766323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aortic valve stenosis: an active atheroinflammatory process.
    Helske S; Kupari M; Lindstedt KA; Kovanen PT
    Curr Opin Lipidol; 2007 Oct; 18(5):483-91. PubMed ID: 17885417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo aortic valve thermal heterogeneity in patients with nonrheumatic aortic valve stenosis the: first in vivo experience in humans.
    Toutouzas K; Drakopoulou M; Synetos A; Tsiamis E; Agrogiannis G; Kavantzas N; Patsouris E; Iliopoulos D; Theodoropoulos S; Yacoub M; Stefanadis C
    J Am Coll Cardiol; 2008 Aug; 52(9):758-63. PubMed ID: 18718425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcific aortic valve disease and aortic atherosclerosis--two faces of the same disease?
    Ginghină C; Florian A; Beladan C; Iancu M; Călin A; Popescu BA; Jurcuţ R
    Rom J Intern Med; 2009; 47(4):319-29. PubMed ID: 21179913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unicommissural aortic valves: gross, histological, and immunohistochemical analysis of 52 cases (1978-2008).
    Fealey ME; Edwards WD; Miller DV; Maleszewski JJ
    Cardiovasc Pathol; 2012; 21(4):324-33. PubMed ID: 22206734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could activated tissue remodeling be considered as early marker for progressive valve degeneration? Comparative analysis of checkpoint and ECM remodeling gene expression in native degenerating aortic valves and after bioprosthetic replacement.
    Yeghiazaryan K; Skowasch D; Bauriedel G; Schild H; Golubnitschaja O
    Amino Acids; 2007 Jan; 32(1):109-14. PubMed ID: 16874466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy of aortic stenosis-success or failure?
    Dimitrow PP; Jawien M; Rajtar-Salwa R
    Curr Pharm Biotechnol; 2012 Oct; 13(13):2497-502. PubMed ID: 22280424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of calcific aortic valve stenosis-fact or fiction?
    Cawley PJ; Otto CM
    Ann Med; 2009; 41(2):100-8. PubMed ID: 18720096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Is secondary myocardial hypertrophy a physiological or pathological adaptive mechanism?].
    Krayenbühl HP
    Z Kardiol; 1982 Aug; 71(8):489-96. PubMed ID: 6215776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.